Immunohistochemical detection of PAX-FOXO1 fusion proteins in alveolar rhabdomyosarcoma using breakpoint specific monoclonal antibodies
David O. Azorsa(Scottsdale Community College), Javed Khan(Kent State University), Paul S. Meltzer(National Cancer Institute), Beat W. Schäfer(University Children's Hospital Zurich), Marco Wachtel(University Children's Hospital Zurich), Ulrike Camenisch(University Hospital Zurich), Peter K. Bode(Kantonsspital Winterthur), Huy Leng Khov(University Hospital Zurich), Christian Vokuhl(University Hospital Schleswig-Holstein), Adam Tai Chi Cheuk(National Cancer Institute), Beata Bode(University Hospital Zurich)
Cited by 34
Related Papers
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
|Nature Medicine|2001|2.7k
Comprehensive Genomic Analysis of Rhabdomyosarcoma Reveals a Landscape of Alterations Affecting a Common Genetic Axis in Fusion-Positive and Fusion-Negative Tumors
|Cancer Discovery|2014|789
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
|Nature Medicine|2015|711